Approximately 50 % of all men and a third of all women develop cancer during their lifetime. The best way to beat cancer is by detecting it early, while it is still confined to the organ of origin and consequently has the best prognosis for successful treatment.
There is a need for tests that contribute in identifying people who are likely to have early stage colorectal cancer and therefore require further examination – such as colonoscopy 820-PVT17263
Such tests can be used:
- by physicians to screen patients
- to screen a population as part of a national program
NorDiag is developing a novel non-invasive stool-based DNA test for the screening/diagnosis of such patients.
NorDiag is also developing a test which will detect cancer mutations from lung biopsies in order to optimise the treatment for lung cancer patients.